查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1672094

全球融合活检市场研究报告 - 产业分析、规模、份额、成长、趋势和预测 2025 年至 2033 年

Global Fusion Biopsy Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033
出版日期: | 出版商: Value Market Research | 英文 242 Pages | 商品交期: 最快1-2个工作天内

价格

全球融合活检市场规模预计将从 2024 年的 13.4 亿美元增长到 2033 年的 27.5 亿美元，在 2026 年至 2033 年的预测期内呈现 8.3% 的强劲年复合成长率(CAGR)。

受影像技术的进步和前列腺癌发病率不断上升的推动，融合活检市场正在经历显着增长。融合活检将传统超音波成像与磁振造影（MRI）相结合，以提高前列腺癌诊断的准确性。这种创新方法可以对可疑病变进行有针对性的取样，提高临床显着癌症的检测率，同时最大限度地减少不必要的活检。随着人们对前列腺癌认识的提高和筛检指南的不断发展，对融合活检程序的需求预计将增加，从而使该市场实现强劲扩张。

此外，对个人化医疗的日益重视正在影响融合活检领域。透过提供有关肿瘤特征的更精确信息，融合活检使医疗保健提供者能够根据个别患者制定治疗计划。这种向标靶治疗的转变在肿瘤学中尤其重要，了解肿瘤的具体生物学可以显着影响治疗结果。随着医疗保健系统越来越多地采用精准医疗方法，融合活检市场可能会受益于先进诊断工具的整合，从而增强患者护理并优化资源利用率。

此外，微创手术的兴起正在推动融合活检技术的采用。越来越多的患者寻求减少不适和恢復时间的选择，使融合活检成为传统活检方法的一种有吸引力的替代方案。使用者友善设备和针对医疗保健专业人员的培训计划的开发进一步促进了这项技术的采用。随着融合活检市场不断发展，持续的研究和创新将在扩大其应用范围和提高诊断准确性方面发挥关键作用，最终有助于在对抗前列腺癌的斗争中取得更好的患者治疗效果。

我们的报告经过精心製作，为客户提供有关各个行业和市场的全面且可操作的见解。每份报告都包含几个关键部分，以确保彻底了解市场格局：

市场概览：市场的详细介绍，包括定义、分类和行业现状概述。

市场动态：深入分析影响市场成长的关键驱动因素、限制因素、机会与挑战。本节探讨技术进步、监管变化和新兴趋势等因素。

細項分析：根据产品类型、应用、最终用户和地理位置等标准将市场细分为不同的细分市场。该分析强调了每个部分的表现和潜力。

竞争格局：对主要市场参与者的全面评估，包括其市场份额、产品组合、策略倡议和财务表现。本节深入介绍领先公司的竞争动态和关键策略。

市场预测：根据历史资料和当前市场状况，预测特定时期内的市场规模和成长趋势。这包括定量分析和图形表示来说明未来的市场轨迹。

区域分析：评估不同地理区域的市场表现，确定关键市场和区域趋势。这有助于了解区域市场动态和机会。

新兴趋势与机会：识别当前和新兴的市场趋势、技术创新和潜在投资领域。本节提供未来市场发展和成长前景的见解。

目录

第 1 章：前言

  • 报告描述
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法
    • 市场研究流程
    • 市场研究方法

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：融合活检产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业趋势
  • 波特五力分析
  • 市场吸引力分析
    • 依技术目标进行市场吸引力分析
    • 按产品进行市场吸引力分析
    • 市场吸引力分析：按应用
    • 依技术进行市场吸引力分析
    • 市场吸引力分析：按地区

第四章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料製造商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球融合活检市场分析：按技术目标

  • Tech Target 概述
  • Tech Target 的历史与预测资料分析
  • 脱氧核糖核酸
  • 核糖核酸
  • 蛋白质

第 6 章：全球融合活检市场分析：按产品

  • 产品概览
  • 按产品进行的历史和预测数据分析
  • 多基因组合
  • 单基因检测
  • 伴随诊断
  • 仅供研究使用 (RUO) 的试剂盒

第 7 章：全球融合活检市场分析：按应用

  • 概述：按应用
  • 历史和预测数据分析：按应用
  • 肿瘤学
  • 神经病学
  • 传染病
  • 心血管疾病

第 8 章：全球融合活检市场分析：按技术

  • 技术概览
  • 按技术进行的历史和预测数据分析
  • 新一代定序 (NGS)
  • 聚合酶炼式反应（PCR）
  • 数位 PCR
  • 奈米串科技

第 9 章：全球融合切片市场分析：按地区划分

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概述、历史和预测数据销售分析
    • 北美各细分市场销售分析
    • 北美各国销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概述、历史和预测数据销售分析
    • 欧洲各细分市场销售分析
    • 欧洲各国销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概述、历史和预测数据销售分析
    • 亚太地区分部销售分析
    • 亚太地区国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概述、历史和预测数据销售分析
    • 拉丁美洲各细分市场销售分析
    • 拉丁美洲各国销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概述、历史和预测数据销售分析
    • 中东和非洲分部销售分析
    • 中东和非洲国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东和非洲其他地区销售分析

第 10 章：融合活检公司的竞争格局

  • 融合切片市场竞争
  • 伙伴关係/合作/协议
  • 合併与收购
  • 新产品发布
  • 其他进展

第 11 章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Hologic Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Exact Sciences Corporation
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Myriad Genetics Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • BioRad Laboratories Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Invivoscribe
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Leica Biosystems
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Affymetrix Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Qiagen NV
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • BD (Becton
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Dickinson And Company)
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Agilent Technologies Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Genomic Health
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Sysmex Corporation
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Beckman Coulter Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Thermo Fisher Scientific Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Illumina Inc
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态

注意 - 在公司简介中，财务细节和最新发展取决于可用性，对于私人公司，可能不予涵盖

Product Code: VMR11216669

Global Fusion Biopsy Market size is anticipated to grow from USD 1.34 Billion in 2024 to USD 2.75 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 8.3% during the forecast period of 2026 to 2033.

The fusion biopsy market is experiencing significant growth, driven by advancements in imaging technologies and the increasing prevalence of prostate cancer. Fusion biopsy combines traditional ultrasound imaging with magnetic resonance imaging (MRI) to enhance the accuracy of prostate cancer diagnosis. This innovative approach allows for targeted sampling of suspicious lesions, improving the detection rate of clinically significant cancers while minimizing unnecessary biopsies. As awareness of prostate cancer rises and screening guidelines evolve, the demand for fusion biopsy procedures is expected to increase, positioning this market for robust expansion.

Moreover, the growing emphasis on personalized medicine is influencing the fusion biopsy landscape. By providing more precise information about tumor characteristics, fusion biopsy enables healthcare providers to tailor treatment plans to individual patients. This shift towards targeted therapies is particularly relevant in oncology, where understanding the specific biology of a tumor can significantly impact treatment outcomes. As healthcare systems increasingly adopt precision medicine approaches, the fusion biopsy market is likely to benefit from the integration of advanced diagnostic tools that enhance patient care and optimize resource utilization.

Additionally, the rise of minimally invasive procedures is driving the adoption of fusion biopsy techniques. Patients are increasingly seeking options that reduce discomfort and recovery time, making fusion biopsy an attractive alternative to traditional biopsy methods. The development of user-friendly devices and training programs for healthcare professionals is further facilitating the adoption of this technology. As the fusion biopsy market continues to evolve, ongoing research and innovation will play a crucial role in expanding its applications and improving diagnostic accuracy, ultimately contributing to better patient outcomes in the fight against prostate cancer.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Tech Target

  • DNA
  • RNA
  • Protein

By Product

  • Multi-gene Panels
  • Single-gene Tests
  • Companion Diagnostics
  • Research Use Only (RUO) Kits

By Application

  • Oncology
  • Neurology
  • Infectious Diseases
  • Cardiovascular Diseases

By Technology

  • Next-Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Digital PCR
  • NanoString Technologies
  • COMPANIES PROFILED
  • Hologic Inc.
  • Exact Sciences Corporation
  • Myriad Genetics Inc.
  • BioRad Laboratories Inc.
  • Invivoscribe
  • Leica Biosystems
  • Affymetrix Inc.
  • QIAGEN N.V.
  • BD (Becton
  • Dickinson and Company)
  • Agilent Technologies Inc.
  • Genomic Health
  • Sysmex Corporation
  • Beckman Coulter Inc.
  • Thermo Fisher Scientific Inc.
  • Illumina Inc.
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. FUSION BIOPSY INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porters Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Tech Target
    • 3.7.2 Market Attractiveness Analysis By Product
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By Technology
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL FUSION BIOPSY MARKET ANALYSIS BY TECH TARGET

  • 5.1. Overview By Tech Target
  • 5.2. Historical and Forecast Data Analysis By Tech Target
  • 5.3. DNA Historic and Forecast Sales By Regions
  • 5.4. RNA Historic and Forecast Sales By Regions
  • 5.5. Protein Historic and Forecast Sales By Regions

6. GLOBAL FUSION BIOPSY MARKET ANALYSIS BY PRODUCT

  • 6.1. Overview By Product
  • 6.2. Historical and Forecast Data Analysis By Product
  • 6.3. Multi-gene Panels Historic and Forecast Sales By Regions
  • 6.4. Single-gene Tests Historic and Forecast Sales By Regions
  • 6.5. Companion Diagnostics Historic and Forecast Sales By Regions
  • 6.6. Research Use Only (RUO) Kits Historic and Forecast Sales By Regions

7. GLOBAL FUSION BIOPSY MARKET ANALYSIS BY APPLICATION

  • 7.1. Overview By Application
  • 7.2. Historical and Forecast Data Analysis By Application
  • 7.3. Oncology Historic and Forecast Sales By Regions
  • 7.4. Neurology Historic and Forecast Sales By Regions
  • 7.5. Infectious Diseases Historic and Forecast Sales By Regions
  • 7.6. Cardiovascular Diseases Historic and Forecast Sales By Regions

8. GLOBAL FUSION BIOPSY MARKET ANALYSIS BY TECHNOLOGY

  • 8.1. Overview By Technology
  • 8.2. Historical and Forecast Data Analysis By Technology
  • 8.3. Next-Generation Sequencing (NGS) Historic and Forecast Sales By Regions
  • 8.4. Polymerase Chain Reaction (PCR) Historic and Forecast Sales By Regions
  • 8.5. Digital PCR Historic and Forecast Sales By Regions
  • 8.6. NanoString Technologies Historic and Forecast Sales By Regions

9. GLOBAL FUSION BIOPSY MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE FUSION BIOPSY COMPANIES

  • 10.1. Fusion Biopsy Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF FUSION BIOPSY INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Hologic Inc.
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Exact Sciences Corporation
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Myriad Genetics Inc.
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. BioRad Laboratories Inc.
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Invivoscribe
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. Leica Biosystems
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. Affymetrix Inc.
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Qiagen N.V.
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. BD (Becton
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. Dickinson And Company)
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments
  • 11.13. Agilent Technologies Inc.
    • 11.13.1 Company Overview
    • 11.13.2 Company Revenue
    • 11.13.3 Products
    • 11.13.4 Recent Developments
  • 11.14. Genomic Health
    • 11.14.1 Company Overview
    • 11.14.2 Company Revenue
    • 11.14.3 Products
    • 11.14.4 Recent Developments
  • 11.15. Sysmex Corporation
    • 11.15.1 Company Overview
    • 11.15.2 Company Revenue
    • 11.15.3 Products
    • 11.15.4 Recent Developments
  • 11.16. Beckman Coulter Inc.
    • 11.16.1 Company Overview
    • 11.16.2 Company Revenue
    • 11.16.3 Products
    • 11.16.4 Recent Developments
  • 11.17. Thermo Fisher Scientific Inc.
    • 11.17.1 Company Overview
    • 11.17.2 Company Revenue
    • 11.17.3 Products
    • 11.17.4 Recent Developments
  • 11.18. Illumina Inc
    • 11.18.1 Company Overview
    • 11.18.2 Company Revenue
    • 11.18.3 Products
    • 11.18.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Tech Target (0 and USD MN)
  • DNA Market Sales By Geography (0 and USD MN)
  • RNA Market Sales By Geography (0 and USD MN)
  • Protein Market Sales By Geography (0 and USD MN)
  • Analysis By Product (0 and USD MN)
  • Multi-gene Panels Market Sales By Geography (0 and USD MN)
  • Single-gene Tests Market Sales By Geography (0 and USD MN)
  • Companion Diagnostics Market Sales By Geography (0 and USD MN)
  • Research Use Only (RUO) Kits Market Sales By Geography (0 and USD MN)
  • Analysis By Application (0 and USD MN)
  • Oncology Market Sales By Geography (0 and USD MN)
  • Neurology Market Sales By Geography (0 and USD MN)
  • Infectious Diseases Market Sales By Geography (0 and USD MN)
  • Cardiovascular Diseases Market Sales By Geography (0 and USD MN)
  • Analysis By Technology (0 and USD MN)
  • Next-Generation Sequencing (NGS) Market Sales By Geography (0 and USD MN)
  • Polymerase Chain Reaction (PCR) Market Sales By Geography (0 and USD MN)
  • Digital PCR Market Sales By Geography (0 and USD MN)
  • NanoString Technologies Market Sales By Geography (0 and USD MN)
  • Global Fusion Biopsy Market Sales By Geography (0 and USD MN)
  • North America Market Analysis (0 and USD MN)
  • United States Market Analysis (0 and USD MN)
  • Canada Market Analysis (0 and USD MN)
  • Mexico Market Analysis (0 and USD MN)
  • Europe Market Analysis (0 and USD MN)
  • Europe Market Estimate By Country (0 and USD MN)
  • United Kingdom Market Analysis (0 and USD MN)
  • France Market Analysis (0 and USD MN)
  • Germany Market Analysis (0 and USD MN)
  • Italy Market Analysis (0 and USD MN)
  • Russia Market Analysis (0 and USD MN)
  • Spain Market Analysis (0 and USD MN)
  • Rest of Europe Market Analysis (0 and USD MN)
  • Asia Pacific Market Analysis (0 and USD MN)
  • China Market Analysis (0 and USD MN)
  • Japan Market Analysis (0 and USD MN)
  • India Market Analysis (0 and USD MN)
  • South Korea Market Analysis (0 and USD MN)
  • Australia Market Analysis (0 and USD MN)
  • South East Asia Market Analysis (0 and USD MN)
  • Rest of Asia Pacific Market Analysis (0 and USD MN)
  • Latin America Market Analysis (0 and USD MN)
  • Brazil Market Analysis (0 and USD MN)
  • Argentina Market Analysis (0 and USD MN)
  • Peru Market Analysis (0 and USD MN)
  • Chile Market Analysis (0 and USD MN)
  • Rest of Latin America Market Analysis (0 and USD MN)
  • Middle East & Africa Market Analysis (0 and USD MN)
  • Saudi Arabia Market Analysis (0 and USD MN)
  • UAE Market Analysis (0 and USD MN)
  • Israel Market Analysis (0 and USD MN)
  • South Africa Market Analysis (0 and USD MN)
  • Rest of Middle East and Africa Market Analysis (0 and USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Fusion Biopsy Report
  • Market Research Process
  • Market Research Methodology
  • Global Fusion Biopsy Market Size, By Region (0 and USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Tech Target
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By Technology
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Tech Target (0 and USD MN)
  • DNA Market Sales By Geography (0 and USD MN)
  • RNA Market Sales By Geography (0 and USD MN)
  • Protein Market Sales By Geography (0 and USD MN)
  • Global Market Analysis By Product (0 and USD MN)
  • Multi-gene Panels Market Sales By Geography (0 and USD MN)
  • Single-gene Tests Market Sales By Geography (0 and USD MN)
  • Companion Diagnostics Market Sales By Geography (0 and USD MN)
  • Research Use Only (RUO) Kits Market Sales By Geography (0 and USD MN)
  • Global Market Analysis By Application (0 and USD MN)
  • Oncology Market Sales By Geography (0 and USD MN)
  • Neurology Market Sales By Geography (0 and USD MN)
  • Infectious Diseases Market Sales By Geography (0 and USD MN)
  • Cardiovascular Diseases Market Sales By Geography (0 and USD MN)
  • Global Market Analysis By Technology (0 and USD MN)
  • Next-Generation Sequencing (NGS) Market Sales By Geography (0 and USD MN)
  • Polymerase Chain Reaction (PCR) Market Sales By Geography (0 and USD MN)
  • Digital PCR Market Sales By Geography (0 and USD MN)
  • NanoString Technologies Market Sales By Geography (0 and USD MN)
  • Global Market Sales (0 and USD MN)
  • North America Market Sales (0 and USD MN)
  • Europe Market Sales (0 and USD MN)
  • Asia Pacific Market Sales (0 and USD MN)
  • Latin America Market Sales (0 and USD MN)
  • Middle East & Africa Market Sales (0 and USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.